Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

Cancer statistics, 2006.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ.

CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30.

PMID:
16514137
[PubMed - indexed for MEDLINE]
2.

Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire.

Karagas MR, Tosteson TD, Morris JS, Demidenko E, Mott LA, Heaney J, Schned A.

Cancer Causes Control. 2004 Jun;15(5):465-72.

PMID:
15286466
[PubMed - indexed for MEDLINE]
3.
4.

Expectant management of small, recurrent, noninvasive papillary bladder tumors.

Soloway MS, Bruck DS, Kim SS.

J Urol. 2003 Aug;170(2 Pt 1):438-41.

PMID:
12853794
[PubMed - indexed for MEDLINE]
5.

A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years.

Larsson P, Wijkström H, Thorstenson A, Adolfsson J, Norming U, Wiklund P, Onelöv E, Steineck G.

Scand J Urol Nephrol. 2003;37(3):195-201.

PMID:
12775276
[PubMed - indexed for MEDLINE]
6.

Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.

Oosterhuis JW, Schapers RF, Janssen-Heijnen ML, Pauwels RP, Newling DW, ten Kate F.

J Clin Pathol. 2002 Dec;55(12):900-5.

PMID:
12461053
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression.

Samaratunga H, Makarov DV, Epstein JI.

Urology. 2002 Aug;60(2):315-9.

PMID:
12137833
[PubMed - indexed for MEDLINE]
8.

Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy.

Holmäng S, Andius P, Hedelin H, Wester K, Busch C, Johansson SL.

J Urol. 2001 Apr;165(4):1124-8; discussion 1128-30.

PMID:
11257652
[PubMed - indexed for MEDLINE]
9.

Prospective registration of all patients in a geographical region with newly diagnosed bladder carcinomas during a two-year period.

Holmäng S, Hedelin H, Anderström C, Holmberg E, Johansson SL.

Scand J Urol Nephrol. 2000 Apr;34(2):95-101.

PMID:
10903069
[PubMed - indexed for MEDLINE]
10.

Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma.

Cheng L, Neumann RM, Nehra A, Spotts BE, Weaver AL, Bostwick DG.

Cancer. 2000 Apr 1;88(7):1663-70.

PMID:
10738225
[PubMed - indexed for MEDLINE]
11.
12.

Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population.

Karagas MR, Tosteson TD, Blum J, Morris JS, Baron JA, Klaue B.

Environ Health Perspect. 1998 Aug;106 Suppl 4:1047-50.

PMID:
9703491
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer.

Kiemeney LA, Witjes JA, Heijbroek RP, Verbeek AL, Debruyne FM.

J Urol. 1993 Jul;150(1):60-4.

PMID:
8510276
[PubMed - indexed for MEDLINE]
14.

Clinical prognostic factors in transitional cell cancer of the bladder.

Lipponen PK, Eskelinen M, Jauhiainen K, Terho R, Harju E.

Urol Int. 1993;50(4):192-7.

PMID:
8506588
[PubMed - indexed for MEDLINE]
15.

Smoking and bladder cancer risk in blacks and whites in the United States.

Hartge P, Silverman DT, Schairer C, Hoover RN.

Cancer Causes Control. 1993 Jul;4(4):391-4.

PMID:
8347788
[PubMed - indexed for MEDLINE]
16.

The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years.

Holmäng S, Hedelin H, Anderström C, Johansson SL.

J Urol. 1995 Jun;153(6):1823-6; discussion 1826-7.

PMID:
7752327
[PubMed - indexed for MEDLINE]
17.

Prognostic parameters in superficial bladder cancer: an analysis of 315 cases.

Lutzeyer W, Rübben H, Dahm H.

J Urol. 1982 Feb;127(2):250-2.

PMID:
7062375
[PubMed - indexed for MEDLINE]
18.

Invasive bladder cancer: tumor configuration, lymphatic invasion and survival.

Heney NM, Proppe K, Prout GR Jr, Griffin PP, Shipley WU.

J Urol. 1983 Nov;130(5):895-7.

PMID:
6632095
[PubMed - indexed for MEDLINE]
19.

Urothelial atypia concomitant with primary bladder tumour. Incidence in a consecutive series of 500 unselected patients.

Wolf H, Olsen PR, Fischer A, Højgaard K.

Scand J Urol Nephrol. 1987;21(1):33-8.

PMID:
3589521
[PubMed - indexed for MEDLINE]
20.

Multivariate evaluation of prognostic determinants in bladder cancer patients.

Takashi M, Murase T, Mizuno S, Hamajima N, Ohno Y.

Urol Int. 1987;42(5):368-74.

PMID:
3433584
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk